NCT01755247View on ClinicalTrials.gov

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Acne Vulgaris
Interventions
DRUG

Topical Gel Vehicle

DRUG

8% NVN1000 Topical Gel

DRUG

8% NVN1000 Topical Gel and moisturizer

Trial Locations (1)

19008

KGL, Inc, Broomall

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT01755247 - A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers | Biotech Hunter | Biotech Hunter